Diagnostics

Company to market noninvasive test for blood hematocrit

Published in Biotech Business Week, August 9th, 2004

Haemonetics Corp. (HAE) announced it will market Crit-Scan, a device to measure the hematocrit in blood without a painful needle stick to the finger or ear.

Haemonetics and Hema Metrics Corp. of Kaysville, Utah, the developer and manufacturer of Crit-Scan, have signed an agreement for exclusive worldwide marketing effective for 5 years. No other terms of the agreement were disclosed.

Haemonetics will market Crit-Scan to blood collectors who are required to measure a blood donor's hematocrit prior to donation to confirm the level of a donor's red blood cells. Traditionally, blood collectors have used a needle stick to the finger or earlobe of a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2004-08-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry